Raf-1 Protein Kinase is Required for Growth of Induced NIH/3T3 Cells
Authors
Affiliations
Many growth factors regulate the cytoplasmic Raf-1 protein kinase, consistent with its having a central role in transduction of growth signals. The kinase is ubiquitously expressed and can promote proliferation, presumably in a manner dependent on growth-factor receptors and membrane-associated oncogenes. We have now examined the dependence of serum- and TPA (12-O-tetradecanoylphorbol-13-acetate)-regulated NIH/3T3 cell growth on RAF-1 kinase to determine whether Raf-1 is essential for receptor signalling. We inhibited Raf-1 function by expressing c-raf-1 antisense RNA or kinase-defective c-raf-1 mutants. Antisense RNA for c-raf-1 interferes with proliferation of normal NIH/3T3 cells and reverts raf-transformed cells. In revertant cells, DNA replication induced by serum or TPA was eliminated or reduced proportionately to the reduction in Raf protein levels. Expression of a kinase-defective Raf-1 mutant (craf301) or a regulatory domain fragment (HCR) inhibited serum-induced NIH/3T3-cell proliferation and raf transformation even more efficiently. Inhibition by antisense RNA or craf301 blocked proliferation and transformation by Ki- and Ha-ras oncogenes. We conclude that raf functions as an essential signal transducer downstream of serum growth factor receptors, protein kinase C and ras.
Unravelling molecular dynamics in living cells: Fluorescent protein biosensors for cell biology.
Sanchez C, Ramirez A, Hodgson L J Microsc. 2024; .
PMID: 38357769 PMC: 11324865. DOI: 10.1111/jmi.13270.
Vujovic F, Shepherd C, Witting P, Hunter N, Farahani R Antioxidants (Basel). 2023; 12(10).
PMID: 37891951 PMC: 10604469. DOI: 10.3390/antiox12101873.
Anti-proliferative effect of extracts on breast cancer cells.
Veisaga M, Ahumada M, Soriano S, Acuna L, Zhang W, Leung I Biocell. 2023; 47(8):1835-1852.
PMID: 37771344 PMC: 10538365.
Pan Y, Yu H, Lu F Technol Cancer Res Treat. 2023; 22:15330338231178639.
PMID: 37248611 PMC: 10240878. DOI: 10.1177/15330338231178639.
Perrone F, Mazzaschi G, Minari R, Verze M, Azzoni C, Bottarelli L Cancers (Basel). 2022; 14(8).
PMID: 35454926 PMC: 9031288. DOI: 10.3390/cancers14082019.